diff --git a/quarto/catalog/fda-table_04/index.qmd b/quarto/catalog/fda-table_04/index.qmd
index 88caf101..8e066a69 100644
--- a/quarto/catalog/fda-table_04/index.qmd
+++ b/quarto/catalog/fda-table_04/index.qmd
@@ -27,7 +27,7 @@ The following trial populations are reflected in Table 4: Subject Populations be
 
 **Customization**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 ::::
 
diff --git a/quarto/catalog/fda-table_06/index.qmd b/quarto/catalog/fda-table_06/index.qmd
index d4e944b5..494c2e82 100644
--- a/quarto/catalog/fda-table_06/index.qmd
+++ b/quarto/catalog/fda-table_06/index.qmd
@@ -15,7 +15,7 @@ categories: [table, FDA, safety, exposure]
 
 **Background and Instructions**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 **Customization**
 
diff --git a/quarto/catalog/fda-table_10/index.qmd b/quarto/catalog/fda-table_10/index.qmd
index e7a9ff49..f33e28b0 100644
--- a/quarto/catalog/fda-table_10/index.qmd
+++ b/quarto/catalog/fda-table_10/index.qmd
@@ -15,11 +15,11 @@ categories: [table, FDA, safety, adverse events]
 
 **Background and Instructions**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 **Customization**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 ::::
 
diff --git a/quarto/catalog/fda-table_12/index.qmd b/quarto/catalog/fda-table_12/index.qmd
index 025131f5..1038f6cb 100644
--- a/quarto/catalog/fda-table_12/index.qmd
+++ b/quarto/catalog/fda-table_12/index.qmd
@@ -15,11 +15,11 @@ categories: [table, FDA, safety, adverse events]
 
 **Background and Instructions**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 **Customization**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 ::::
 
diff --git a/quarto/catalog/fda-table_38/index.qmd b/quarto/catalog/fda-table_38/index.qmd
index e858836f..2e0c9995 100644
--- a/quarto/catalog/fda-table_38/index.qmd
+++ b/quarto/catalog/fda-table_38/index.qmd
@@ -15,7 +15,7 @@ categories: [table, FDA, safety, vital signs]
 
 **Background and Instructions**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 **Customization**
 
diff --git a/quarto/catalog/fda-table_43/index.qmd b/quarto/catalog/fda-table_43/index.qmd
index 42c49138..b1b218ce 100644
--- a/quarto/catalog/fda-table_43/index.qmd
+++ b/quarto/catalog/fda-table_43/index.qmd
@@ -15,11 +15,11 @@ categories: [table, FDA, safety, adverse events]
 
 **Background and Instructions**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 **Customization**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 ::::
 
diff --git a/quarto/catalog/fda-table_44/index.qmd b/quarto/catalog/fda-table_44/index.qmd
index 3c5f63f2..45b9d910 100644
--- a/quarto/catalog/fda-table_44/index.qmd
+++ b/quarto/catalog/fda-table_44/index.qmd
@@ -19,7 +19,7 @@ As discussed in Section 3.2.3.3 Subjects With Adverse Events by Sex-Specific OND
 
 **Customization**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 ::::
 
diff --git a/quarto/catalog/fda-table_45/index.qmd b/quarto/catalog/fda-table_45/index.qmd
index 584e80ae..f7862930 100644
--- a/quarto/catalog/fda-table_45/index.qmd
+++ b/quarto/catalog/fda-table_45/index.qmd
@@ -19,7 +19,7 @@ As discussed in Section 3.2.3.3 Subjects With Adverse Events by Sex-Specific OND
 
 **Customization**
 
-N/A (per FDA IG)
+[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)
 
 ::::